Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple MyelomaAnna Luise Grab, Marc S. Raab, Lukas John et al.|Cells|2024Cited by 18